loader
Please Wait
Applying Filters...
menu
    • menu

    Drug Product Composition: NCGC00024596-07

    Client Email Product
    Menu

    NCGC00024596-07

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    PRICE INFORMATION

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 361Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 19856 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    carbidopa(UNII: MNX7R8C5VO)
    (CARBIDOPA ANHYDROUS - UNII:KR87B45RGH)     		CARBIDOPA ANHYDROUS50mg | 25mg
    levodopa(UNII: 46627O600J)
    (levodopa - UNII:46627O600J)     		levodopa200mg | 100mg

    Inactive Ingredients

    Ingredient Name
    Merck Sharp & Dohme Corp.
    ALUMINUM OXIDE(LMI26O6933)
    FD&C BLUE NO. 2(L06K8R7DQK)
    FD&C RED NO. 40(WZB9127XOA)
    HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P)
    HYPROMELLOSE 2208 (3 MPA.S)(9H4L916OBU)
    INDIGOTINDISULFONATE SODIUM(D3741U8K7L)
    magnesium stearate(70097M6I30)